Keywords: AED; antiepileptic drug; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; EIAED; enzyme-inducing antiepileptic drug; IGE; idiopathic generalised epilepsy; ILAE; International League Against Epilepsy; TEAE; treatment-emergent adverse event; Ant
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Domoic acid; Dopaminergic neurons; Parkinson's disease; Neurotoxicity; Marine; In vitro; AMPA; KA;
Keywords: AE; adverse event; AED; antiepileptic drug; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; CBZ; carbamazepine; CYP; cytochrome P450; EIAED; enzyme-inducing antiepileptic drug; LOCF; last observation carried forward; OC; observed case; PB; ph
Keywords: Biopurification systems; Biobeds; Herbicide; Wastewater; AMPA;
Keywords: AED; antiepileptic drug; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; CDR; Cognitive Drug Research; COWAT; Controlled Oral Word Association; EIAED; enzyme-inducing antiepileptic drug; IGF-1; insulin-like growth factor-1; LGPT; Lafayette Gr
Keywords: Hydrogen sulfide; Gasotransmitter; Sulfhydration; Neurodegeneration; Oxidative stress; Antioxidants; 3-MST; 3-mercaptopyruvate sulfurtransferase; 4-HNE; 4-hydroxynonenal; 6-OHDA; 6-hydroxydopamine; Aβ; β-Îmyloid; AD; Alzheimer's disease; ALS; Amyotro
Keywords: AMPA; α-Amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid; AP; action potential; APfreq; AP frequency; ATP; Adenosine triphosphate; [Ca2+]; Calcium concentration; ECD; excitotoxic cell death; FCCP; Carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone;
Keywords: AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ANNA; anti-neuronal nuclear antibody; APS; antiphospholipid syndrome; ARHGAP26; Ca/RhoGTPase-activating protein 26; CaMKII; calcium calmodulin-dependent protein kinase II; CASPR2; contactin-asso
Keywords: LTP; Dorsal hippocampus; Dopamine 5 receptor; RT-qPCR; LTD; Corticosterone; AMPA; alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic; AMPK; adenosine monophosphate-activated protein kinase; BDNF; brain-derived neurotrophic factor; ENS; exercise no stress
Keywords: AMPA; α-amino-3-hydroxy-5-methyl-4-isoazolepropionic acid; OPC; oligodendrocyte precursor cell; MBP; myelin basic protein; PDGFRα; platelet-derived growth factor receptor alpha; CNPase; cyclic nucleotide phosphodiesterase; olig2; oligodendrocyte transcr
Keywords: Roundup; AMPA; Residues; Antibiotic resistance; Microbial community; Plant and animal health;
Keywords: 5-HT; 5-hydroxytryptamine; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; CAMKII; Calcium/calmodulin-dependent protein kinase II; CaV; voltage-gated calcium (channel); CGRP; calcitonin gene-related peptide; CB; cannabinoid receptor; CNS; cen
Keywords: AFM; (mixed) amplitude and frequency modulation; AM; amplitude modulation; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ATP; adenosine triphosphate; BC; basket cell; ER; endoplasmic reticulum; FM; frequency modulation; GABA; γ-aminobutyri
Keywords: Chronic pain; Motivated behavior; Reward; Limbic system; Addiction; VTA; ventral tegmental area; SN; substantia nigra; PFC; prefrontal cortex; mPFC; medial prefrontal cortex; NAc; nucleus accumbens; BLA; basolateral amygdala; CeA; central amygdala; PBn; p
Keywords: AMPA; 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl) propionate; Biph.; biphasic; CCD; charge-coupled device; CMOS; complementary metal-oxide-semiconductor; CNQX; 6-cyano-7-nitroquinoxaline-2,3-dione; DHM; digital holographic microscope; DNAse; deoxyribo
Keywords: AM; adrenomedulin; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; AMY; amylin; AT; angiotensin type; β-CCT; beta-carboline-3-carboxylate-t-butyl ester; CT; calcitonin; CTR; calcitonin receptor; CLR; calcitonin receptor-like receptor; DZ; di
Keywords: 4-HNE; 4-Hydroxynonenal; AA; Arachidonic acid; AD; Alzheimer's Disease; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic; AMPAR; α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; aNSC; Adult neural stem cells; APC; Adenomatous polyposi
Keywords: Transcranial electrical stimulation; tDCS; tACS; tRNS; Neuromodulation; Animal models; AC; alternating current; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; BDNF; brain-derived neurotrophic factor; DC; direct current; EEG; electroencephalo
Keywords: 3-HK; 3-hydroxykynurenine; 3-NP; 3-nitropropionic acid; 6âOHDA; 6-hydroxidopamine; AADC; aromatic amino acid decarboxylase; ACA; anterior cerebral artery; ADP; adenosine-5â²-diphosphate; ALDH; aldehyde dehydrogenases; ALS; amyotrophic lateral sclerosis
Keywords: CaMKII; calcium/calmodulin dependent protein kinase type II; NMDAR; N-methyl-d-aspartate receptor; GluN2B; full length GluN2B subunit of NMDAR; MLS-NR2B; GluN2B residues 1271-1311 with a mitochondrial localizing sequence; MK-801; (5S,10R-(+)-5-Methyl-10
Keywords: AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; AMPAR; AMPA receptor; AP5; 2-amino-5-phosphonopentanoic acid; ATPA; (RS)-2-Amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl) propanoic acid; AUC; area under the curve; CNS; central nervous system; C
Keywords: ÎΨ; Mitochondrial membrane potential; Aβ; Amyloid beta; AD; Alzheimer's disease; AMPA; α-amino-3-hydroxy-5-methylisoxazole-4-propionate; ApoE/D; Apolipoproteins E/D; BBB; Blood brain barrier; GSH; glutathione; HD; Huntington's disease; H2O2; hydrogen
Keywords: Parkinson's disease; Ghrelin; Dementia; AHN; adult hippocampal neurogenesis; AD; Alzheimer's Disease; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; AMPK; AMP-activated protein kinase; AB; amyloid-β; ATG; autophagy-related; BBB; blood brain
Keywords: AD; Alzheimer's disease; Aβ; β-amyloid peptide; NFTs; neurofibrillary tangles; EOAD; early-onset AD; LOAD; late-onset AD; OMOT; One-molecule-one-target; ROS; reactive oxygen species; CDMT; Combination-drugs-multi-targets; BBB; blood brain barrier; DDT;
Keywords: Jiadifenolide; Bilobalide; Neurotrophic; Neurodegenerative disorders; Convulsions; AMPA; α-amino-3-hydroxy-5-methyl- 4-isoxazolepropionic acid; AP-4; 4-Aminopyridine; CTZ; cyclothiazide; PAM; positive allosteric modulator; PI; protective index; PTZ; pent
Keywords: AHP; afterhyperpolarization; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; APD; action potential duration; APV; 2-amino-5-phosphonovaleric acid; DNQX; 6,7-dinitroquinoxaline-2,3-dione; EC; entorhinal cortex; GABA; γ-aminobutyric acid; i.p.
Keywords: Early life adversity; Synapses; Stress; AMPA; NMDA; Memory;
Keywords: Aβ; β-amyloid; Aβo; oligomers of Aβ; ACTH; adrenocorticotropic hormone; AD; Alzheimer's disease; AMPA; amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl) propanoic acid; APP; amyloid-precursor protein; AT; angiotensin; BBB; blood brain barrier; BCM; Bienens
Keywords: Synaptic model; STP; LTP; AMPA; NMDA; Glutamatergic synapse; Dendritic activity;
Keywords: Pituitary; Ligand-gated receptor channels; G protein-coupled receptors; Neurotransmitters; Action potentials; Calcium signaling; Hormone secretion; ACh; acetylcholine; mAChR; muscarinic ACh receptor; nAChR; nicotinic ACh receptor; AP; action potential; AM
Keywords: Aβ; amyloid β; AD; Alzheimer's disease; AMPA; 2-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; APP; amyloid precursor protein; AUD; alcohol use disorder; BZDs; benzodiazepines; EAATs; excitatory amino acid transporters; EW; ethanol withdrawal; GA
Keywords: AGAP; anti-tumor analgesic peptide; AMPA; α-amino-3-hydroxy-5methylisoxazole-4-propionic acid; ASICs; acid-sensitive ion channels; ATP; adenosine triphosphate; Bmk; toxin isolated from Chinese scorpion Mesobuthus martensii (previously Buthus martensii Ka
Keywords: AMPA; α-amino-3-hydroxy-5-methyl-4- isoxazole propionic acid; ASI; Axon-spine interface; Ca2+; calcium; CNS; Central nervous system; CS-EP; Corticostriatal-evoked potential; DBS; deep brain stimulation; DA; Dopamine; DARPP-32; dopamine-regulated neuronal
Keywords: Neural circuits; Reinstatement; Self-administration; Ventral pallidum; Voluntary abstinence; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; BLA; basolateral amygdala; BNST; bed nucleus of the stria terminalis; CeA; central amygdala nucleus;
Keywords: AC; adenylate cyclase; ADHD; attention deficit hyperactivity disorder; ACC; anterior cingulate cortex; ALS; amyotrophic lateral sclerosis; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ATP; adenosine triphosphate; BBB; blood-brain barrier;
Keywords: ACTH; adrenocorticotropic hormone; AChR; acetylcholine receptor; ALS; amyotrophic lateral sclerosis; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; Ca2+; a calcium ion; CA1; cornu ammonis area 1, a region in the hippocampus anatomy; CO2; car
Keywords: AUD; Alcohol use disorder; FDA; Food and Drug Administration; MOR; Mu opioid receptor; DOR; Delta opioid receptor; KOR; Kappa opioid receptor; NMDA; N-methyl-d-aspartate; GABA; Gaba amino butyric acid; DSM-IV; Diagnostic and statistical measurement IV; PA
Keywords: 5-HT; 5-hydroxytryptamine; AA; arachidonic acid; ACh; acetylcholine; ACTH; adrenocorticotrophic hormone; AD; Alzheimer's Disease; ADP; adenosine diphosphate; Aβ; amyloid β; AMP; adenosine monophosphate; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepro
Keywords: ACh; Acetylcholine; A-P; Anterior-posterior; AChE; Acetylcholinesterase; AD; Alzheimer's disease; Akt; Serine/threonine kinase; ALA; Aplpha linoleic acid; AM; Amygdala; AMPA; α-Amino- 3-hydroxy-5-methyl-4-isoxazolepropionic acid; AP-7; 2-amino-7-phosph
Keywords: AD; Alzheimer's disease; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ApoE; apolipoprotein E; BBB; blood brain barrier; BDNF; brain-derived neurotrophic factor; CNS; central nervous system; CRP; C-reactive protein; GABA; gamma-aminobutyr
Keywords: ALS; Amyotrophic lateral sclerosis; DMD; DuchenneMuscular Dystrophy; SMA; Spinalmuscular atrophy; FAP; FamilialAmyloid Polyneuropathy; OD; Orphandisease; ORD; Officeof Rare Diseases; NIH; NationalInstitutes of Health; sALS; SporadicALS; fALS; FamilialALS;
Keywords: AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; α-SMA; alpha- smooth muscle actin; BBB; blood-brain barrier; BDNF; brain derived neurotrophic factor; bFGF or FGF2; basic fibroblast growth factor; BrdU; bromodeoxyuridine; CIMT; const
Keywords: Hippocampus; Cytokines; Inflammation; Epilepsy; Activated microglia; ASD; Anti-Seizure Drug; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ATP; Adenosine Triphosphate; DAMP; Danger Associated Molecular Pattern; FS; Febrile Seizures; GABA; G
Keywords: AMPA; Breathing; Glutamate; Hypoglossal nucleus; Nicotine; Desensitization;
Keywords: AED; antiepileptic drugs; AMPA; alpha amino-3-hydroxy-5-methylisoxazole-4-propionic acid; ANOVA; analysis of variance; DAB; diaminobenzidine; DZP; diazepam; EEG; electroencephalogram; GABAA; γ-aminobutyric acid receptor type A; NeuN; neuronal nuclei; PBS
Keywords: MSQA; Midwestern Stream Quality Assessment; POEA; polyethoxylated amines; IARC; International Agency for Research on Cancer; EFSA; European Food Safety Authority; USGS; U.S. Geological Survey; EPA; U.S. Environmental Protection Agency; NRSA; National Rive
Keywords: Aβ; amyloid-β; ADAM; a disintegrin and metalloproteinase; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid; APP; amyloid precursor protein; CAM; cell adhesion molecule; CaMK; calcium-calmodulin dependent kinase; DCC; deleted in colorectal ca
Keywords: Autism; Pathophysiology; Neurons; Models; Cav; L-type voltage-gated calcium channel; NMDA; N-methyl-D-aspartate receptor; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; mGluR; metabotropic glutamate receptor; CaMKII; Ca2+/calmodulin
Keywords: 5-HIAA; 5-hydroxyindoleacetic acid; 5-HT; 5-hydroxytryptamine; ACTH; adrenocorticotropic hormone; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; AMPK; AMP-activated protein kinase; BDNF; brain-derived neurotrophic factor; DBS; Deep Brain Sti
Keywords: Green tea; Cognitive functioning; Brain functions; AMPA; aminomethylphosphonic acid; DELPHI; structured communication technique that relies on a panel of experts; DLPFC; dorsolateral prefrontal cortex; Dyrk1A; dual specificity tyrosine-(Y)-phosphorylation